A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy
Condition: Primary Membranous Nephropathy Interventions: Drug: Zanubrutinib; Drug: Tacrolimus Sponsor: BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2023 Category: Research Source Type: clinical trials
Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS
Condition: Sjogren Syndrome With Other Organ Involvement Interventions: Drug: Prednisolone; Drug: Tacrolimus Sponsor: Peking Union Medical College Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2023 Category: Research Source Type: clinical trials